Responses
Treating Idiopathic Pulmonary Fibrosis
P174 Effect of continued treatment with pirfenidone following a ≥10% relative decline in percent predicted forced vital capacity (%FVC) in patients with idiopathic pulmonary fibrosis (IPF)
Compose a Response to This Article
Other responses
No responses have been published for this article.